Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 147

  • Filters activated: AIDS. Clear all to show 15203 items.
1.

Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi's Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya.

Busakhala NW, Waako PJ, Strother MR, Keter AK, Kigen GK, Asirwa FC, Loehrer PJ.

J Glob Oncol. 2018 Sep;(4):1-9. doi: 10.1200/JGO.17.00077.

2.

CXCR4/Let-7a Axis Regulates Metastasis and Chemoresistance of Pancreatic Cancer Cells Through Targeting HMGA2.

Xiao G, Wang X, Yu Y.

Cell Physiol Biochem. 2017;43(2):840-851. doi: 10.1159/000481610. Epub 2017 Sep 28.

3.

Fluorinated nucleosides as an important class of anticancer and antiviral agents.

Cavaliere A, Probst KC, Westwell AD, Slusarczyk M.

Future Med Chem. 2017 Oct;9(15):1809-1833. doi: 10.4155/fmc-2017-0095. Epub 2017 Sep 20. Review.

PMID:
28929804
4.

Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies.

Chiaravalli M, Reni M, O'Reilly EM.

Cancer Treat Rev. 2017 Nov;60:32-43. doi: 10.1016/j.ctrv.2017.08.007. Epub 2017 Aug 23. Review.

PMID:
28869888
5.

Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model.

Novalić Z, Verkuijlen SAWM, Verlaan M, Eersels JLH, de Greeuw I, Molthoff CFM, Middeldorp JM, Greijer AE.

J Med Virol. 2017 Dec;89(12):2207-2216. doi: 10.1002/jmv.24870. Epub 2017 Aug 29.

6.

Metformin-induced alterations in nucleotide metabolism cause 5-fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinoma.

Mynhardt C, Damelin LH, Jivan R, Peres J, Prince S, Veale RB, Mavri-Damelin D.

J Cell Biochem. 2018 Jan;119(1):1193-1203. doi: 10.1002/jcb.26291. Epub 2017 Aug 23.

PMID:
28722177
7.

Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer.

Liu C, Cheng H, Luo G, Lu Y, Jin K, Guo M, Ni Q, Yu X.

Int J Oncol. 2017 Aug;51(2):686-694. doi: 10.3892/ijo.2017.4032. Epub 2017 Jun 7.

PMID:
28714519
8.

Antiviral activity of gemcitabine against human rhinovirus in vitro and in vivo.

Song JH, Kim SR, Heo EY, Lee JY, Kim DE, Cho S, Chang SY, Yoon BI, Seong J, Ko HJ.

Antiviral Res. 2017 Sep;145:6-13. doi: 10.1016/j.antiviral.2017.07.003. Epub 2017 Jul 11.

PMID:
28705625
9.

Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer.

Ullenhag GJ, Mozaffari F, Broberg M, Mellstedt H, Liljefors M.

PLoS One. 2017 Jan 18;12(1):e0169736. doi: 10.1371/journal.pone.0169736. eCollection 2017.

10.

Prognostic Differences: Epstein-Barr Virus-Associated Primary Leiomyosarcoma of the Spine Versus Spinal Leiomyosarcoma Metastases.

Agarwal N, Hansberry DR, Kavi A, Agarwal P, Baisre A, Goldstein IM.

World Neurosurg. 2017 Mar;99:484-490. doi: 10.1016/j.wneu.2016.12.035. Epub 2016 Dec 21.

PMID:
28011357
11.

Significant impact of divalent metal ions on the fidelity, sugar selectivity, and drug incorporation efficiency of human PrimPol.

Tokarsky EJ, Wallenmeyer PC, Phi KK, Suo Z.

DNA Repair (Amst). 2017 Jan;49:51-59. doi: 10.1016/j.dnarep.2016.11.003. Epub 2016 Nov 25.

PMID:
27989484
12.

Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity.

Jiang Y, Hou J, Li X, Huang Y, Wang X, Wu J, Zhang J, Xu W, Zhang Y.

Bioorg Med Chem. 2016 Nov 15;24(22):5787-5795. doi: 10.1016/j.bmc.2016.09.033. Epub 2016 Sep 14.

PMID:
27670098
13.

Antitumor effects of herbal mixture extract in the pancreatic adenocarcinoma cell line PANC1.

Pak PJ, Kang BH, Park SH, Sung JH, Joo YH, Jung SH, Chung N.

Oncol Rep. 2016 Nov;36(5):2875-2883. doi: 10.3892/or.2016.5067. Epub 2016 Sep 5.

PMID:
27599899
14.

Rapidly Progressing Refractory Hodgkin Lymphoma: A Case Report and a Possible Explanation.

Jóna Á, Irsai G, Barna S, Méhes G, Illés Á, Váróczy L.

Case Rep Med. 2016;2016:7698624. doi: 10.1155/2016/7698624. Epub 2016 Jun 26.

15.

The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR4.

García-Santos EP, Padilla-Valverde D, Villarejo-Campos P, Murillo-Lázaro C, Fernández-Grande E, Palomino-Muñoz T, Rodríguez-Martínez M, Amo-Salas M, Nuñez-Guerrero P, Sánchez-García S, Puerto-Puerto A, Martín-Fernández J.

Pancreatology. 2016 Jul-Aug;16(4):632-9. doi: 10.1016/j.pan.2016.04.031. Epub 2016 May 12.

PMID:
27289344
16.

The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells.

Al-Assar O, Bittner MI, Lunardi S, Stratford MR, McKenna WG, Brunner TB.

Radiother Oncol. 2016 May;119(2):300-5. doi: 10.1016/j.radonc.2016.03.024. Epub 2016 May 28.

PMID:
27247056
17.

Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.

Morimoto M, Matsuo Y, Koide S, Tsuboi K, Shamoto T, Sato T, Saito K, Takahashi H, Takeyama H.

BMC Cancer. 2016 May 12;16:305. doi: 10.1186/s12885-016-2340-z.

18.

ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.

Wilson JM, Fokas E, Dutton SJ, Patel N, Hawkins MA, Eccles C, Chu KY, Durrant L, Abraham AG, Partridge M, Woodward M, O'Neill E, Maughan T, McKenna WG, Mukherjee S, Brunner TB.

Radiother Oncol. 2016 May;119(2):306-11. doi: 10.1016/j.radonc.2016.03.021. Epub 2016 Apr 23.

19.

Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein.

Liu X, Xu Z, Hou C, Wang M, Chen X, Lin Q, Song R, Lou M, Zhu L, Qiu Y, Chen Z, Yang C, Zhu W, Shao J.

Biochem Pharmacol. 2016 Mar 1;103:118-28. doi: 10.1016/j.bcp.2016.01.003. Epub 2016 Jan 13.

PMID:
26774458
20.

Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy.

Hanoun N, Gayral M, Pointreau A, Buscail L, Cordelier P.

Hum Gene Ther. 2016 Feb;27(2):184-92. doi: 10.1089/hum.2015.151.

Supplemental Content

Loading ...
Support Center